Trader’s Recap : Emergent BioSolutions (NYSE:EBS), Conatus Pharmaceuticals (NASDAQ:CNAT), Cabot Microelectronics (NASDAQ:CCMP), MakeMyTrip (NASDAQ:MMYT), Vision-Sciences Inc. (NASDAQ:VSCI)
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has submitted a Biologics License Application to the U.S. Food and Drug Administration (FDA) for Anthrax Immune Globulin Intravenous (Human) [AIGIV] as part of a development contract with the Biomedical Advanced Research and Development Authority (BARDA). AIGIV, which was acquired in the Cangene acquisition completed earlier this year,…
